Another Ozempic side effect? Facing the holidays with no appetite
Weight-loss medications tamp down hunger — often dramatically — causing some people to lose the pleasure of communing over food at a festive family meal.
Wegovy
FDA approves Zepbound, a new obesity drug that will take on Wegovy
Eli Lilly said the obesity medicine, which helped adults in clinical studies lose about 20% of their body weight, will be available in the U.S. by the end of the year. The list price will be $1,060.
Less snacking, more satisfaction: Some foods boost levels of an Ozempic-like hormone
Popular weight-loss drugs mimic GLP-1, a hormone the body makes naturally after eating. Turns out some foods trigger GLP-1 better than others, making us feel full and eat less.
Ozempic seems to curb cravings for alcohol. Here's what scientists think is going on
People taking weight-loss drugs Ozempic and Wegovy report a dampening of the urge to drink. Here's how the drugs curb cravings and what that could mean for helping treat addiction.
Ozempic and Wegovy maker courts prominent Black leaders to get Medicare's favor
Drugmaker Novo Nordisk focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease — worth treating at a cost of $1,000 or more a month.
'You forget to eat': How Ozempic went from diabetes medicine to blockbuster diet drug
The Novo Nordisk diabetes medication was found to cause significant weight loss in users and has since become a blockbuster drug and very big business.
Wegovy works. But here's what happens if you can't afford to keep taking the drug
The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.